NCT06893068

Brief Summary

This study aims to evaluate the effectiveness of a clinical intelligent management system, based on a multimodal foundational model, in improving the quality of primary care at a community health service center. Using a prospective, randomized controlled, single-blind study design, the trial will include primary care physicians and adult patients seeking care at the Tiantongyuanbei Community Health Service Center and Shanghai Health and Medical Center. Physicians in the intervention group will utilize the intelligent management system with AR glasses to aid in diagnosis and treatment, while patients will engage with the system's patient interface to access health education, follow-up reminders, and AI-powered home consultation features. In contrast, physicians in the control group will provide routine diagnoses and treatments, with their patients receiving standard health education and follow-up care. The trial was designed with the assistance of a digital twin-based clinical research system (termed X Town). By comprehensively evaluating diagnostic quality, physicians' clinical abilities, patient-reported outcomes, and system appraisals, this study will assess the effectiveness of the clinical intelligent management system in enhancing the quality of primary care and patient management.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
204

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

April 13, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

3 months

First QC Date

February 12, 2025

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comprehensive Assessment of clinical performance

    Primary Care Quaility Assessment Scales (range: 0 to 100 for each case; the higher scores means the better performance)

    From enrollment to the end of treatment at 3 months of all recruited cases

Secondary Outcomes (1)

  • AI-System's appraisal

    At the end of 3 months

Study Arms (2)

AI-assist group

EXPERIMENTAL

Physicians in the intervention group will employ the intelligent management system with AR glasses to assist in diagnosis and treatment, while patients will interact with the system's patient interface to access health education, follow-up reminders, and AI-powered home consultation features.

Device: AI-based clinical intelligent management system

Traditional group

NO INTERVENTION

Physicians in the control group will conduct routine diagnoses and treatments, while patients will receive standard health education and follow-up care.

Interventions

The clinical intelligent management system, integrated with AR glasses and powered by a multimodal foundational model, is designed to improve the quality of outpatient care at community health service centers.

AI-assist group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Receiving care at a community health service center
  • Able to understand and comply with the study procedures
  • Agrees to participate in the study and signs the informed consent form

You may not qualify if:

  • Patients with severe mental illness
  • Patients unable to independently complete the questionnaire
  • Patients expected to be unable to complete follow-ups within three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Health and Medical Center

Wuxi, Jiangsu, 214065, China

RECRUITING

Study Officials

  • Tien Yin Wong

    Tsinghua University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 12, 2025

First Posted

March 25, 2025

Study Start

April 13, 2025

Primary Completion

June 30, 2025

Study Completion

July 31, 2025

Last Updated

May 16, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations